Morning Briefing
Summaries of health policy coverage from major news organizations
The Lipitor Story: Drug Companies Brace For Losses As Patent Expires
News outlets analyze the impact that generic Lipitor could have on costs and the "era of 'blockbuster drugs'" as well as the strategies from Lipitor's maker to block its generic competitors. Meanwhile, some of these generics are already reaching the marketplace.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
